COMMUNIQUÉS West-GlobeNewswire

Active Biotech has received an indicative bid for the property in Lund - the Board is positive
01/02/2019
As previously reported, Active Biotech's property Forskaren 1 in Lund has been on sale for a period of time. Active Biotech has now received an indicative, non-binding bid for the property, amounting to SEK 275 million [...]
Typenex® Medical Awarded National MAGNET GROUP Contract
01/02/2019
Gives Members Access to Full Portfolio of Patient Identification Products CHICAGO, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Typenex Medical , an industry leader in Healthcare, announced it has been awarded the MAGNET GROUP GPO [...]
Outlook Therapeutics Closes Final Tranche of $20 Million Private Placement
01/02/2019
CRANBURY, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”) today announced that it closed on the final tranche (of four) of its $20.0 million private placement of common [...]
Former Assistant U.S. Attorney Joins Phoenix Life Sciences International as Company’s Vice President of Regulatory Affairs
01/02/2019
DENVER, CO, Feb. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that [...]
HMS to Report Fourth Quarter 2018 Financial Results on February 22, 2019
01/02/2019
IRVING, Texas, Feb. 01, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the fourth quarter and year ended December 31, 2018 at 7:30 am CT / 8 [...]
Milestone Scientific Announces Pricing of $2.0 Million Offering of Common Stock and Warrants
01/02/2019
LIVINGSTON, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the [...]
Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on Friday, March 1, 2019
01/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]
OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer
01/02/2019
MIAMI, Feb. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s point-of-care Sangia Total Prostate Specific Antigen ( [...]
AroCell launches new website
01/02/2019
Today AroCell is launching its new website. The goal with the new website is to facilitate for our customers, business partner, and investors to find relevant information about AroCell. The website (arocell.com) informs [...]
Auris Medical Announces Full Repayment of Hercules Loan Facility
01/02/2019
Zug, Switzerland, February 1, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Dentsply Sirona to Host Fourth Quarter and Full Year 2018 Conference Call on March 1st
01/02/2019
YORK, Pa., Feb. 01, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Friday, March 1 [...]
AVROBIO, Inc. Announces Time Change for Analyst and Investor Presentation and Webcast, now 5:30 p.m. ET on Wednesday, February 6, 2019
01/02/2019
CAMBRIDGE, Mass., Feb. 01, 2019 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced a time change for its analyst and investor presentation [...]
Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction
01/02/2019
INDIANAPOLIS and STAMFORD, CT, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY) (“Lilly”) and Loxo Oncology, Inc. (NASDAQ: LOXO) (“Loxo Oncology”) today announced the expiration of the waiting period [...]
Abeona Therapeutics présentera de nouvelles données de soutien pour les nouvelles thérapies géniques au WORLDSymposium™
01/02/2019
NEW YORK et CLEVELAND, 01 févr. 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), société biopharmaceutique de stade clinique de premier plan spécialisée dans le développement de nouvelles thérapies [...]
Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres
01/02/2019
MELBOURNE, Australia, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the execution of a 3-way [...]
Immunicum AB (publ) Announces Upcoming Investor Events in February
01/02/2019
Press Release 1 February 2019 Immunicum AB (publ) Announces Upcoming Investor Events in February Immunicum AB (publ; IMMU.ST) announced today that Carlos de Sousa, CEO of Immunicum, and other members of the management [...]
Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
01/02/2019
Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide Sales remained broadly unchanged in Danish kroner and increased [...]
DBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference
01/02/2019
Montrouge, France, February 1, 2019 DBV Technologies to Present at the 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a [...]
DBV Technologies invitée à presenter à la 8th Annual Leerink Partners Global Healthcare Conference
01/02/2019
Montrouge, France, le 1 février (7h30 CET), 2019 DBV Technologies invitée à presenter à la 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN : FR0010417345 - Nasdaq Stock [...]

Pages